Table 2.
Unadjusted rates of each individual outcome of the non‐fatal serious adverse outcome composite among patients with HFrEF (ejection fraction <50%) and HFpEF (ejection fraction ≥50%)
| Clinical outcome | EF phenotype | 30 day outcome rate |
|---|---|---|
| Intra‐arterial balloon pump | HFpEF | 0.05% |
| HFrEF | 0.02% | |
| Endotracheal intubation | HFpEF | 1.11% |
| HFrEF | 1.24% | |
| Renal failure requiring dialysis | HFpEF | 1.60% |
| HFrEF | 1.59% | |
| Myocardial infarction (MI) or coronary revascularization | HFpEF | 7.35% |
| HFrEF | 15.28% |
EF, ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction.